CVS Health Corporation
CVS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $96 | $87 | $85 | $57 |
| - Cash | $9 | $12 | $10 | $9 |
| + Debt | $82 | $83 | $81 | $83 |
| Enterprise Value | $168 | $158 | $157 | $131 |
| Revenue | $103 | $99 | $95 | $98 |
| % Growth | 4% | 4.6% | -3.2% | – |
| Gross Profit | $14 | $14 | $14 | $13 |
| % Margin | 13.4% | 13.7% | 15.2% | 13.2% |
| EBITDA | -$2 | $4 | $5 | $4 |
| % Margin | -1.5% | 3.6% | 4.8% | 4.1% |
| Net Income | -$4 | $1 | $2 | $2 |
| % Margin | -3.9% | 1% | 1.9% | 1.7% |
| EPS Diluted | -3.13 | 0.8 | 1.41 | 1.3 |
| % Growth | -491.3% | -43.3% | 8.5% | – |
| Operating Cash Flow | $1 | $2 | $5 | $2 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | $0 | $1 | $4 | $1 |